Neurocrine Biosciences ( NBIX) discovers, develops and commercializes drugs for the treatment of neurological and endocrine-related diseases and disorders. This stock closed up 3.4% at $14.98 in Wednesday's trading session.
Wednesday's Volume: 1.19 million
Three-Month Average Volume: 570,184
Volume % Change: 115%
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts